Southeastern Asset Management · portfolio as of Q2 2026, filed Aug 14, 2026
Latest 13F filing: Q2 2026 (filed Aug 14, 2026). No newer filing yet.
12 of 33 holdings are Undervalued or On Sale by our valuation (44% of the money).
On Sale: MGM, TRIP.
Valued by PaybackPrice; holdings from SEC 13F filings as of Jun 30, 2026. 14 not valued.
Mason Hawkins's portfolio holds 47 stocks worth $1.9B at the end of Q2 2026. The largest positions are RYN, MAT, CNX, PPLI and ACI.
In Q2 2026, Mason Hawkins opened 3 new positions (ABT, PPLI and TME) and added to ACI, AVTR, SAM, CNX, ESRT, GLIBK and REGN.
In Q2 2026, Mason Hawkins sold out of BIO, STZ, FI, IAC and CLVT and trimmed ACMR, FDX, FBIN, GHC, HTHT, KSPI, MGM, MLCO, EDU, PVH, RYN, SHEN, TRIP, SN and MICC.
MAT, ACI, KHC, FDX, MGM, ESRT, WTM, TRIP, FIS, SAM, MLCO and HDB are Undervalued or On Sale by our valuation.
Latest 13F filing: Q2 2026 (filed Aug 14, 2026). No newer filing yet.
From SEC Form 13F-HR — up to 45 days old at time of filing. Not a recommendation to buy or sell. Analyze any of these free →